Average cost of drugs for extensively drug-resistant tuberculosis in Mozambique
Mozambique: Average cost of drugs for extensively drug-resistant tuberculosis was 5,675 constant 2022 US$ in 2024. ▲ Rising
Average cost of drugs for extensively drug-resistant tuberculosis in Mozambique, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of drugs for extensively drug-resistant tuberculosis in Mozambique stood at 5,675 constant 2022 US$. That is the highest value across all 8 years on record.
That represents a change of up 76.8% over ten years.
That places Mozambique 7th out of 56 countries with data for 2024, putting it in the top quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Mozambique, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 3,210 constant 2022 US$ | — |
| 2018 | 3,037 constant 2022 US$ | -5.4% |
| 2019 | 4,446 constant 2022 US$ | +46.4% |
| 2020 | 4,446 constant 2022 US$ | +0.0% |
| 2021 | 4,446 constant 2022 US$ | +0.0% |
| 2022 | 4,446 constant 2022 US$ | +0.0% |
| 2023 | 5,675 constant 2022 US$ | +27.6% |
| 2024 | 5,675 constant 2022 US$ | +0.0% |
Mozambique compared with similar countries
- Mozambique's 5,675 constant 2022 US$ is above the median for low income countries, which is 1,709 constant 2022 US$, 3.3× the median. (9 countries reporting)
- Mozambique's 5,675 constant 2022 US$ is above the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 3.8× the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,564 constant 2022 US$ | 3,037 constant 2022 US$ | 4,446 constant 2022 US$ | 3 |
| 2020s | 4,938 constant 2022 US$ | 4,446 constant 2022 US$ | 5,675 constant 2022 US$ | 5 |
Countries ranked near Mozambique
More reference data data for Mozambique
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 2.06 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 1.78 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 4.53 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.2808 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 4.53 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 6.9 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 9.3 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 8.28 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 27.89 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 1.53 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Mozambique?
- Average cost of drugs for extensively drug-resistant tuberculosis in Mozambique was 5,675 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Mozambique?
- The highest recorded value was 5,675 constant 2022 US$ in 2023.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Mozambique?
- The lowest recorded value was 3,037 constant 2022 US$ in 2018.
- How does Mozambique rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Mozambique ranks 7th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Mozambique?
- Over the last ten years it is up 76.8%. The long-run trend across the full record is rising.
- Where does this Mozambique data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.